Search for: "US v. Palmer" Results 1 - 20 of 581
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Mar 2024, 1:03 pm by NARF
Federal Courts Bulletinhttps://www.narf.org/nill/bulletins/federal/2024.html Soto Palmer, et al. v. [read post]
23 Feb 2024, 12:34 pm by John Elwood
That brings us to this week’s second new relist, Sandoval v. [read post]
19 Feb 2024, 8:55 am by Lawrence Solum
Nevertheless, recognizing the conservative judiciary’s potential hostility to that distinction, the Article practices ideological jujitsu by redeploying Palmer v. [read post]
19 Feb 2024, 4:00 am by Michael C. Dorf
The Fourth Circuit makes this point, saying that plaintiffs failed to prove that the proper measurement is "before and after," but it’s opinion does not explain why that isn’t the right baseline.My explanation uses ideological jujitsu to invoke Palmer v. [read post]
16 Feb 2024, 5:35 am by Andrew Lavoott Bluestone
Co. of Am. v Dewey, Ballantine, Bushby, Palmer & Wood, 80 NY2d 377, 382-385 [1992] [attorney may be held liable to third parties for submitting a false opinion letter upon which a third party relied]). [read post]
12 Dec 2023, 7:15 am by centerforartlaw
Gall’s cultural identity and offered to loan the manuscripts to the Abbey Library.[8] The parties were able to analyze the issues at hand, and split interests into “title” and “use” of the objects. [read post]
20 Oct 2023, 2:40 pm by CFM Admin
This rule also introduces standardized reporting metrics to be used by private funds. [read post]
11 Oct 2023, 3:30 pm by Jacob Fishman
Laura Coordes, ’Til Fraud Do Us Part: Bartenwerfer v. [read post]
8 Oct 2023, 6:46 pm by Kurt R. Karst
  As a reminder, back in February 2023, HPM blogged about DEA’s two proposed rules for prescribing (1) controlled substances generally and (2) for buprenorphine use in opioid treatment. [read post]
16 Jul 2023, 11:56 pm by Kluwer Patent blogger
” 3) How to Distinguish Transformative Fair Uses From Infringing Derivative Works? [read post]